TABLE 1.
Biomarker | Advantage & Utility | Disadvantage & Constraints | GOAL: Diagnostic Biomarker | GOAL: Prognostic Biomarker |
---|---|---|---|---|
NFL Chain Concentration | Plasma and CSF concentrations highly correlated; Sensitive to the initiation of cART | Alterations have been observed in other neurodegenerative diseases (e.g., AD, multiple sclerosis), and thus, it is not disease specific | Inconsistent relationship with NCI that may be driven primarily by cART | In the pre-cART era, increases in NFL concentration were associated with presentation of ADC |
Amyloid and Tau Proteins | Distinct pathology from AD | Invasive procedure needed for CSF measurements | Selective relationships between NCI and protein markers; Unable to distinguish between milder forms of NCI and controls, despite the use of multiple markers | CSF Aβ−42 and p-tau have been utilized as a prognostic biomarker for the conversion from MCI to AD |
Resting-State fMRI | Brief, non-invasive procedure | Currently unclear what changes in BOLD signaling indicate mechanistically; Inconsistencies between studies | Inconsistent relationship between fMRI measures and NCI | No changes in resting-state fMRI relative to controls were observed in a two-year follow-up |
Prepulse Inhibition | Brief, non-invasive procedure; Clinically translational experimental paradigm | Alterations have been observed in other diseases, albeit evidence in other neurodegenerative disease (e.g., AD) is limited | Diagnostic utility generalizes across two experimental paradigms (i.e., cross-modal PPI, gap-PPI), the functional lifespan, sensory modalities, and biological sex; Overall high accuracy, sensitivity, and specificity | Early neurocognitive impairments in PPI predict later alterations in higher order cognitive functions (r≥0.81) |
NFL=Neurofilament Light; CSF=Cerebrospinal Fluid; cART=Combination Antiretroviral Therapy; AD=Alzheimer’s disease; NCI=Neurocognitive Impairments; ADC=AIDS Dementia Complex; Aβ−42=Amyloid β 1–42; MCI=Milder Cognitive Impairment; fMRI=Functional Magnetic Resonance Imaging; BOLD=Blood Oxygenation Level Dependent; PPI=Prepulse Inhibition; gap-PPI=Gap Prepulse Inhibition